• VisEn offers new fluorescence imaging options, enables multi-modal fusion

    APRIL 23, 2009--VisEn Medical (Bedford, MA) this week launched two new offerings and expanded its fluorescence mediated tomography (FMT) platform. Its new FAST (Fluorescent Activatible Sensor Technology) imaging agents enable in vivo monitoring of biomarkers and drug response, and its FMT 2500 imaging platforms offer greater data ranges and multiplexing of biomarkers in vivo. A new adapter series enables data fusion between FMT and other imaging modalities.
    April 23, 2009

    APRIL 23, 2009--During the just-concluded 100th Annual Meeting of the American Association of Cancer Research (AACR, April 18-22, Denver, CO), VisEn Medical Inc. (Bedford, MA), introduced its new FAST ("Fluorescent Activatible Sensor Technology") imaging agent platform for advanced imaging of key disease-associated biomarkers and drug response in vivo.

    Sign up for Laser Focus World Newsletters
    Get the latest news and updates.

    Related

    Case Study: Custom Microlens Arrays Design
    Photonics Hot List: June 13, 2025

    Voice Your Opinion!

    To join the conversation, and become an exclusive member of Laser Focus World, create an account today!